Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2007-04-12 20:50:43 UTC |
---|
Update Date | 2022-03-07 02:49:29 UTC |
---|
HMDB ID | HMDB0006035 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 4-Dihydroboldenone |
---|
Description | 4-Dihydroboldenone is a metabolite of boldenone. Boldenone is an androgenic anabolic steroid (AAS) intensively used for growth-promoting purposes in animals destined for meat production and as a performance enhancer in athletics. Therefore, its use is officially banned in both humans and in animals intended for human consumption. Because most anabolic steroids are completely metabolized and usually no parent steroid is excreted, metabolite identification is crucial to detect the illegal use of anabolic steroids either in humans or in livestock. Androgenic anabolic steroids are defined as natural, synthetic, or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic, and neuroendocrine systems, the AAS has been extensively used in sports activities (PMID: 2663904 , 16195040 , 16292586 , 1663826 , 16799097 , 16888758 , 16923823 , 9249887 ). |
---|
Structure | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)C=C[C@]12C InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,12,14-17,21H,3-6,8,10-11H2,1-2H3/t12-,14+,15+,16+,17+,18+,19+/m1/s1 |
---|
Synonyms | Value | Source |
---|
(5beta,17beta)-17-Hydroxyandrost-1-en-3-one | ChEBI | (5b,17b)-17-Hydroxyandrost-1-en-3-one | Generator | (5Β,17β)-17-hydroxyandrost-1-en-3-one | Generator | 17b-Hydroxy-5b -androst-1-en-3-one | HMDB | 17b-Hydroxy-5b-androst-1-en-3-one | HMDB, Generator | 5b-Androst-1-en-17b-ol-3-one | HMDB | 5b-Androst-1-ene-17b-ol-3-one | HMDB | 5beta-Androst-1-en-17beta-ol-3-one | MeSH, HMDB | Androst-1-en-17-ol-3-one | MeSH, HMDB | 17β-Hydroxy-5β-androst-1-en-3-one | Generator | 17beta-Hydroxy-5beta-androst-1-en-3-one | HMDB | 4-Dihydroboldenone | HMDB | 5beta-Androst-1-ene-17beta-ol-3-one | HMDB | 5β-Androst-1-en-17β-ol-3-one | HMDB | 5β-Androst-1-ene-17β-ol-3-one | HMDB |
|
---|
Chemical Formula | C19H28O2 |
---|
Average Molecular Weight | 288.4244 |
---|
Monoisotopic Molecular Weight | 288.20893014 |
---|
IUPAC Name | (1S,2R,7R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-en-5-one |
---|
Traditional Name | (1S,2R,7R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-en-5-one |
---|
CAS Registry Number | 10529-96-1 |
---|
SMILES | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])CC(=O)C=C[C@]12C |
---|
InChI Identifier | InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,12,14-17,21H,3-6,8,10-11H2,1-2H3/t12-,14+,15+,16+,17+,18+,19+/m1/s1 |
---|
InChI Key | OKJCFMUGMSVJBG-MISPCMORSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 3-oxo-delta-1-steroid
- 3-oxosteroid
- 3-oxo-5-beta-steroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Delta-1-steroid
- Cyclohexenone
- Cyclic alcohol
- Cyclic ketone
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Organooxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Alcohol
- Organic oxide
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-Dihydroboldenone,1TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@@H]4CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2714.1 | Semi standard non polar | 33892256 | 4-Dihydroboldenone,1TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C=C(O[Si](C)(C)C)C=C[C@]34C)[C@@H]1CC[C@@H]2O | 2553.7 | Semi standard non polar | 33892256 | 4-Dihydroboldenone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C=C(O[Si](C)(C)C)C=C[C@]34C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2578.3 | Semi standard non polar | 33892256 | 4-Dihydroboldenone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C=C(O[Si](C)(C)C)C=C[C@]34C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2580.6 | Standard non polar | 33892256 | 4-Dihydroboldenone,2TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C=C(O[Si](C)(C)C)C=C[C@]34C)[C@@H]1CC[C@@H]2O[Si](C)(C)C | 2978.2 | Standard polar | 33892256 | 4-Dihydroboldenone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C | 2973.2 | Semi standard non polar | 33892256 | 4-Dihydroboldenone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=C[C@H]2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C1 | 2826.2 | Semi standard non polar | 33892256 | 4-Dihydroboldenone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C[C@H]2CC[C@H]3[C@@H]4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C1 | 3138.1 | Semi standard non polar | 33892256 | 4-Dihydroboldenone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C[C@H]2CC[C@H]3[C@@H]4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C1 | 3044.9 | Standard non polar | 33892256 | 4-Dihydroboldenone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C[C@H]2CC[C@H]3[C@@H]4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C1 | 3262.8 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 4-Dihydroboldenone GC-MS (Non-derivatized) - 70eV, Positive | splash10-05i9-0490000000-f6ebedc0daa2295b81c9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Dihydroboldenone GC-MS (1 TMS) - 70eV, Positive | splash10-000t-1219000000-33752dbf36217e013441 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Dihydroboldenone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Dihydroboldenone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 10V, Positive-QTOF | splash10-00dr-0090000000-16a979e47d20a140bb20 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 20V, Positive-QTOF | splash10-022i-0290000000-1903847e4640d27ffe3f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 40V, Positive-QTOF | splash10-002o-3890000000-365296df3fe861648302 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 10V, Negative-QTOF | splash10-000i-0090000000-507160a36d5fc98fe109 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 20V, Negative-QTOF | splash10-000i-0090000000-c58084752b6f0048e230 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 40V, Negative-QTOF | splash10-0596-1090000000-79ab60776a39e76e2172 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 10V, Positive-QTOF | splash10-000i-0090000000-b2999bc7d49ce2a4db44 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 20V, Positive-QTOF | splash10-03ki-0960000000-1321f449097600ca5668 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 40V, Positive-QTOF | splash10-0a4i-2900000000-7da59599892bb5ce25b1 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 10V, Negative-QTOF | splash10-000i-0090000000-383f8ad782110ec64fbf | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 20V, Negative-QTOF | splash10-000i-0090000000-383f8ad782110ec64fbf | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Dihydroboldenone 40V, Negative-QTOF | splash10-0uy0-0090000000-50477ff83a0e087a0650 | 2021-09-22 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023811 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 20045328 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 12133279 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 87331 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Masse R, Ayotte C, Dugal R: Studies on anabolic steroids. I. Integrated methodological approach to the gas chromatographic-mass spectrometric analysis of anabolic steroid metabolites in urine. J Chromatogr. 1989 Apr 7;489(1):23-50. [PubMed:2663904 ]
- Saudan C, Baume N, Robinson N, Avois L, Mangin P, Saugy M: Testosterone and doping control. Br J Sports Med. 2006 Jul;40 Suppl 1:i21-4. [PubMed:16799097 ]
- Maughan RJ: Contamination of dietary supplements and positive drug tests in sport. J Sports Sci. 2005 Sep;23(9):883-9. [PubMed:16195040 ]
- Fineschi V, Riezzo I, Centini F, Silingardi E, Licata M, Beduschi G, Karch SB: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med. 2007 Jan;121(1):48-53. Epub 2005 Nov 15. [PubMed:16292586 ]
- VanHelder WP, Kofman E, Tremblay MS: Anabolic steroids in sport. Can J Sport Sci. 1991 Dec;16(4):248-57. [PubMed:1663826 ]
- Thevis M, Schanzer W: Mass spectrometry in sports drug testing: Structure characterization and analytical assays. Mass Spectrom Rev. 2007 Jan-Feb;26(1):79-107. [PubMed:16888758 ]
- Green GA: Doping control for the team physician: a review of drug testing procedures in sport. Am J Sports Med. 2006 Oct;34(10):1690-8. Epub 2006 Aug 21. [PubMed:16923823 ]
- Iversen P: Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group. Scand J Urol Nephrol. 1997 Jun;31(3):249-54. [PubMed:9249887 ]
|
---|